PACS Valuation
| PACS Stock | 36.87 1.02 2.85% |
At this time, the entity appears to be overvalued. PACS Group owns a latest Real Value of USD26.55 per share. The recent price of the entity is USD36.87. Our model determines the value of PACS Group from evaluating the entity fundamentals such as operating margin of 0.0007 %, and Shares Outstanding of 155.18 M as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting PACS's valuation include:
Price Book 6.611 | Enterprise Value | Enterprise Value Ebitda 26.0071 | Price Sales 1.0926 | Forward PE 17.6678 |
Overvalued
Today
Please note that PACS's price fluctuation is slightly risky at this time. Calculation of the real value of PACS Group is based on 3 months time horizon. Increasing PACS's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the PACS stock is determined by what a typical buyer is willing to pay for full or partial control of PACS Group. Since PACS is currently traded on the exchange, buyers and sellers on that exchange determine the market value of PACS Stock. However, PACS's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 36.87 | Real 26.55 | Target 34.67 | Hype 36.87 | Naive 36.0 |
The intrinsic value of PACS's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence PACS's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of PACS Group helps investors to forecast how PACS stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of PACS more accurately as focusing exclusively on PACS's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use PACS's intrinsic value based on its ongoing forecasts of PACS's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against PACS's closest peers.
PACS Cash |
|
About PACS Valuation
The stock valuation mechanism determines PACS's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of PACS Group based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of PACS. We calculate exposure to PACS's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of PACS's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 792.6 M | 513.8 M | |
| Pretax Profit Margin | 0.03 | 0.03 | |
| Operating Profit Margin | 0.03 | 0.03 | |
| Net Profit Margin | 0.02 | 0.01 | |
| Gross Profit Margin | 0.17 | 0.14 |
PACS Quarterly Retained Earnings |
|
PACS Growth Indicators
Investing in growth stocks can be very risky. If the company such as PACS does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 148.6 M | |
| Forward Price Earnings | 17.6678 |
PACS Current Valuation Indicators
PACS's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final PACS's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as PACS, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use PACS's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes PACS's worth.Additional Tools for PACS Stock Analysis
When running PACS's price analysis, check to measure PACS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PACS is operating at the current time. Most of PACS's value examination focuses on studying past and present price action to predict the probability of PACS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PACS's price. Additionally, you may evaluate how the addition of PACS to your portfolios can decrease your overall portfolio volatility.